Atlas Trials

Reducing Neonatal Morbidity by Discontinuing Oxytocin During the Active Phase of 1st Stage of Labor

Clinical trial NCT03991091 · COMPLETED

Trial details

NCT number
NCT03991091
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Neonatal Morbidity
Start date
2020-01-17
Primary completion
2022-04-25
Enrollment
2459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.